Ginkgo Bioworks Holdings, Inc. 2025-2026 Proxy Voting Records

Description as filed by funds: Election of Directors: Christian Henry

Ginkgo Bioworks Holdings, Inc.’s own tally for this item (“Elect Director: Christian Henry”): 94,211,345 for, 13,927,076 against, per its Form 8-K filed June 12, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The results of the vote were as follows: Director nominees designated to be elected by holders of Class B common stock: Director nominees designated to be elected by holders of Class A and Class B common stock (voting together as a single class): Pursuant to the foregoing votes, the six nominees l…”
Support: 87% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 49 asset managers below reported 815,064 for, 4,979,358 against, 9 abstained.

Showing the 25 largest of 49 asset managers. See all 49 in the interactive database.

Description as filed by funds: Election of Directors: Harry E. Sloan

Ginkgo Bioworks Holdings, Inc.’s own tally for this item (“Elect Director: Harry E. Sloan”): 97,315,317 for, 10,788,312 against, per its Form 8-K filed June 12, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The results of the vote were as follows: Director nominees designated to be elected by holders of Class B common stock: Director nominees designated to be elected by holders of Class A and Class B common stock (voting together as a single class): Pursuant to the foregoing votes, the six nominees l…”
Support: 90% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 49 asset managers below reported 3,426,086 for, 2,368,335 against, 9 abstained.

Showing the 25 largest of 49 asset managers. See all 49 in the interactive database.

Description as filed by funds: Election of Directors: Ross Fubini

Ginkgo Bioworks Holdings, Inc.’s own tally for this item (“Elect Director: Ross Fubini”): 100,125,571 for, 7,977,143 against, per its Form 8-K filed June 12, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The results of the vote were as follows: Director nominees designated to be elected by holders of Class B common stock: Director nominees designated to be elected by holders of Class A and Class B common stock (voting together as a single class): Pursuant to the foregoing votes, the six nominees l…”
Support: 93% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 49 asset managers below reported 4,107,225 for, 1,687,196 against, 9 abstained.

Showing the 25 largest of 49 asset managers. See all 49 in the interactive database.

Description as filed by funds: Election of Directors: Sri Kosuri

Ginkgo Bioworks Holdings, Inc.’s own tally for this item (“Elect Director: Sri Kosuri”): 99,675,907 for, 8,421,356 against, per its Form 8-K filed June 12, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The results of the vote were as follows: Director nominees designated to be elected by holders of Class B common stock: Director nominees designated to be elected by holders of Class A and Class B common stock (voting together as a single class): Pursuant to the foregoing votes, the six nominees l…”
Support: 92% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 49 asset managers below reported 4,655,048 for, 1,139,374 against, 9 abstained.

Showing the 25 largest of 49 asset managers. See all 49 in the interactive database.

Description as filed by funds: Advisory vote to approve executive compensation.

Ginkgo Bioworks Holdings, Inc.’s own tally for this item (“3. Advisory vote to approve executive compensation Proposal three was an advisory vote to approve the compensation of the Company's named executive officers, designated to be voted upon by the holders of Class A common s”): 95,058,585 for, 12,502,153 against — passed, per its Form 8-K filed June 12, 2026 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Pursuant to the foregoing vote, the compensation of the Company's named executive officers was approved on an advisory basis.”
Support: 88% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports, all 49 managers: 951,134 for, 4,843,287 against, 11 abstained. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports, all 173 managers: 6,736,831 for, 4,714,214 against, 4,118,973 abstained. Showing the 25 largest; see all in the interactive database.

Description as filed by funds: Ratification of the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026.

Ginkgo Bioworks Holdings, Inc.’s own tally for this item (“2. Ratification of the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm Proposal two was the ratification of the appointment of Deloitte & Touche LLP as the Company's in”): 119,527,721 for, 267,727 against — passed, per its Form 8-K filed June 12, 2026 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Pursuant to the foregoing vote, the ratification of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026 was approved.”
Support: 99.7% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 49 asset managers below reported 5,790,821 for, 3,601 against, 9 abstained.

Showing the 25 largest of 49 asset managers. See all 49 in the interactive database.